Orthofix International | OFIX - Assets


Orthofix International reported $873.02M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 1.04B 29.85M Sep/2026
AtriCure USD 717.54M 40.89M Sep/2026
Dexcom USD 6.24B 216.5M Sep/2026
EDAP TMS EUR 72.06M 10.6M Mar/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.42B 250M Sep/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 873.02M 13.58M Jun/2026
Plus Therapeutics USD 14.03M 5.89M Jun/2026
Smith & Nephew USD 11.01B 321M Jun/2026
STAAR Surgical USD 485.16M 9.95M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
Veracyte USD 1.57B 86.89M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026